People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...
7d
News-Medical.Net on MSNTirzepatide helps people without diabetes lose 13% body weight in real-world studyA real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...
Topline data were announced from a phase 3 trial evaluating CagriSema (cagrilintide/semaglutide) in overweight or obese patients with type 2 diabetes.
The Cost of Weight Loss: A study found that for medications like Wegovy and Zepbound to be cost effective for employers and government programs, they would need to cost hundreds less per month.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results